HCW Biologics Inc.
HCWB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.7% | -57.7% | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 37.4% | 19.7% | 38.5% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,078.4% | -829.6% | -209.1% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,169.7% | -879.5% | -221.7% | – |
| EPS Diluted | -0.77 | -0.7 | -0.41 | -0.35 |
| % Growth | -10% | -70.7% | -17.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |